Recent Updates
Recently added Catalysts

Dermacyd PH_DETINLYN

Phase 3

Hygiene | Small molecule | Other |Sanofi|Last Updated: Aug 25, 2009

Success Probability
Approval Probability 71%
TA Base Rate26%
Adjusted LOA41%
ML RiskLOW_RISK
Premium
Market & Valuation
rNPV $3.2B
Market Size $9.4B
Revenue Basis $1.6B
Competitors 6
Premium
Trial Design
UNCONTROLLEDBiomarker
Total Trials3
Total Enrollment132
FDA Designations
No designations recorded
Clinical Trials (3)
NCT IDTitlePhaseStatusEnrollmentVelocityDesignStartCompletionLast UpdatedSitesCountries
NCT00785590Dermacyd PH_DETINLYN (Lactic Acid) Sweet Flower - Photo Evaluation.PHASE3 COMPLETED 26 — — Aug 1, 2008Sep 1, 2008Aug 25, 20091 Brazil
NCT00785655Dermacyd PH_DETINLYN (Lactic Acid) Sweet Flower - CompatibilityPHASE3 COMPLETED 53 — — Jul 1, 2008Sep 1, 2008Aug 25, 20091 Brazil
NCT00786097Dermacyd PH_DETINLYN (Lactic Acid) Tangerine Mix - CompatibilityPHASE3 COMPLETED 53 — — Jul 1, 2008Sep 1, 2008Aug 25, 20091 Brazil
Unlock Drug Trial Details
Study Endpoints
Primary Endpoints
The photo irritation test and the photosensitivity will be measured using UVA irradiation and evaluated according International Contact Dermatitis Research Group (ICDRG) scale
Throughout the study
The sensibility will be evaluated according to the skin type.
Throughout the study
The absence of primary and accumulated dermical irritability and dermical sensitivity will be evaluated using International Contact Dermatitis Research Group (ICDRG) scale.
Throughout the study
Unlock Study Endpoints
Study Design & Arms
AllocationNON_RANDOMIZED
MaskingNONE
ModelSINGLE_GROUP
PurposeSUPPORTIVE_CARE
Treatment Arms
ArmTypeDescription
1EXPERIMENTALDermacyd PH\_DETINLYN (Lactic Acid)
Interventions
NameTypeDescription
Dermacyd PH_DETINLYN (Lactic Acid)DRUG -
Unlock Study Design Details
Eligibility Criteria
Age Range18 Years — 60 Years
SexFEMALE
Healthy VolunteersYes
Study Sites1

Inclusion criteria: * Phototype Skin II and III; * Integral skin test in the region; * Willingness in following the study procedures and to be present in the clinic at the days and scheduled time for medical evaluations and for application of occlusion; Exclusion criteria: * Lactation or gestatio...

Countries:Brazil
Unlock Eligibility Criteria